Menu

Image of the Day: Dino Tracks

A combination of analysis techniques including 3-D models and false-color depth maps allow researchers to study tridactyl dinosaur tracks in Switzerland.

Apr 12, 2018
The Scientist Staff, The Scientist Staff

Pictures and false-color depth maps of the tracksD. CASTANERA ET AL.

Between 2002 and 2011, paleontologists working in the Swiss Jura Mountains found multiple sets of dinosaur footprints. The tracks were tridactyl, meaning they each had three toes, but some impressions were larger than others, and it was unclear how many or what kind of dinosaurs made the tracks. Recently, the researchers analyzed the footprints using false-color depth maps and 3-D models to determine that various dinosaur species—rather than large and smaller members of the same species—made the tracks. They reported their findings last week (April 2) in PeerJ.

D. Castanera et al., “A walk in the maze: variation in Late Jurassic tridactyl dinosaur tracks from the Swiss Jura Mountains (NW Switzerland),” PeerJ, doi:10.7717/peerj.4579, 2018.

 

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
The National Institute Of Allergy And Infectious Disease recently awarded BellBrook Labs a $300,000 Small Business Innovative Research (SBIR) grant to develop novel inhibitors for the target cyclic GAMP Synthase (cGAS). The grant will be used to accelerate the discovery of new treatments for autoimmune diseases by targeting the cGAS-STING pathway.